AZ Returns Meropenem Rights in Southeast Asia, HK to Sumitomo Dainippon

Sumitomo Dainippon Pharma said on December 26 that AstraZeneca PLC has returned its rights to the carbapenem antibiotic meropenem to the Japanese company in five Southeast Asian countries and Hong Kong. The five countries are Vietnam, Thailand, Singapore, Philippines, and...read more